Neoadjuvant endocrine therapy for breast cancer: An overlooked option? The Wong/Ellis article reviewed

被引：0
作者：
Stearns, V [1 ]
机构：
[1] Johns Hopkins Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA
来源：
ONCOLOGY-NEW YORK | 2004年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：421 / +
页数：3
相关论文
共 50 条
  • [31] Outcomes of Short Course Neoadjuvant Endocrine Therapy in Breast Cancer
    De Andrade, J. P.
    Schroeder, M.
    Leone, J.
    Sugg, S. L.
    Erdahl, L.
    Weigel, R.
    Lizarraga, I.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S9 - S10
  • [32] Neoadjuvant endocrine therapy for breast cancer:: past, present and future
    Barnadas, Agusti
    Gill, Miguel
    Sanchez-Rovira, Pedro
    Llombart, Antonio
    Adrover, Encarna
    Estevez, Laura G.
    de la Haba, Juan
    Calvo, Lourdes
    ANTI-CANCER DRUGS, 2008, 19 (04) : 339 - 347
  • [33] One-Year Neoadjuvant Endocrine Therapy in Breast Cancer
    Rusz, Orsolya
    Voeroes, Andras
    Varga, Zoltan
    Kelemen, Gyoengyi
    Uhercsak, Gabriella
    Nikolenyi, Aliz
    Ormandi, Katalin
    Simonka, Zsolt
    Kahan, Zsuzsanna
    PATHOLOGY & ONCOLOGY RESEARCH, 2015, 21 (04) : 977 - 984
  • [34] ENDOCRINE THERAPY IN BREAST CANCER: THE NEOADJUVANT, ADJUVANT, AND METASTATIC APPROACH
    Reinbolt, Raquel E.
    Mangini, Neha
    Hill, Jordan L.
    Levine, Lauren B.
    Dempsey, Jessica L.
    Singaravelu, Janani
    Koehler, Kevin A.
    Talley, Allison
    Lustberg, Maryam B.
    SEMINARS IN ONCOLOGY NURSING, 2015, 31 (02) : 146 - 155
  • [35] Duration of neoadjuvant endocrine therapy and breast cancer outcomes.
    Mougalian, Sarah Schellhorn
    Soulos, Pamela R.
    Lannin, Donald R.
    Pusztai, Lajos
    Gross, Cary Philip
    Killelea, Brigid K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [36] Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
    Korde, Larissa A.
    Somerfield, Mark R.
    Carey, Lisa A.
    Crews, Jennie R.
    Denduluri, Neelima
    Hwang, E. Shelley
    Khan, Seema A.
    Loibl, Sibylle
    Morris, Elizabeth A.
    Perez, Alejandra
    Regan, Meredith M.
    Spears, Patricia A.
    Sudheendra, Preeti K.
    Symmans, W. Fraser
    Yung, Rachel L.
    Harvey, Brittany E.
    Hershman, Dawn L.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (13) : 1485 - +
  • [37] Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
    Nina Tamirisa
    Kelly K. Hunt
    Annals of Surgical Oncology, 2022, 29 : 1489 - 1492
  • [38] Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
    Tamirisa, Nina
    Hunt, Kelly K.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (03) : 1489 - 1492
  • [39] Adjuvant hormonal therapy in early breast cancer - The Kumar/Leonard article reviewed
    Kaklamani, VG
    Gradishar, WJ
    ONCOLOGY-NEW YORK, 2005, 19 (11): : 1433 - 1434
  • [40] Twenty years of systemic therapy for breast cancer - The Mina/Sledge article reviewed
    Wolff, Antonio C.
    Davidson, Nancy E.
    ONCOLOGY-NEW YORK, 2006, 20 (01): : 33 - +
12345